$23.33
-0.23 (-0.98%)
Open$23.03
Previous Close$23.56
Day High$24.32
Day Low$22.70
52W High$33.20
52W Low$13.89
Volume—
Avg Volume2.13M
Market Cap905.69M
P/E Ratio—
EPS$-2.22
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+224.9% upside
Current
$23.33
$23.33
Target
$75.80
$75.80
$52.19
$75.80 avg
$91.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 7.39M | 78.02M | 75.69M |
| Net Income | -70,586,400 | -16,723,517 | -20,379,208 |
| Profit Margin | -954.4% | -21.4% | -26.9% |
| EBITDA | -72,652,002 | -28,105,243 | -27,281,553 |
| Free Cash Flow | — | -11,355,754 | -12,035,038 |
| Rev Growth | — | -7.7% | +21.3% |
| Debt/Equity | 0.21 | 0.34 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |